Published August 11, 2005 | Version v1
Journal article

Applications of synchrotron X-rays to radiotherapy

  • 1. Institute of Pathology, University of Bern, 3000 Bern (Switzerland)
  • 2. Institute of Pathology, Kantonsspital, Luzern (Switzerland)
  • 3. ESRF, Grenoble (France)
  • 4. PSI, 5232 Villigen (Switzerland)
  • 5. Institute of Anatomy, University of Bern, 3000 Bern (Switzerland)

Description

Radiotherapy is among the most useful treatments of cancer. Penetrating radiation (ionizing particles or bremsstrahlung photons) is aimed toward the tumor-bearing target, gradually delivering as high radiation to it as is usefully suppressive of tumor growth, yet tolerated by normal vital tissues inevitably irradiated with the tumor. The high collimation and dose rate of synchrotron X-ray beams, even when monochromatized, favor radiotherapy. Photon activation therapy, tomotherapy, microbeam radiation therapy, and radiosurgery mediated by synchrotron wigglers are conceptually promising for difficult tumors. Radiotherapy of malignant brain tumors in rats has been encouraging, but suitable beam lines exist at only a few research facilities and much basic work must be done before the promise of synchrotron-based radiotherapy can be realized clinically

Additional details

Identifiers

DOI
10.1016/j.nima.2005.03.060;
PII
S0168-9002(05)00641-8;

Publishing Information

Journal Title
Nuclear Instruments and Methods in Physics Research. Section A, Accelerators, Spectrometers, Detectors and Associated Equipment
Journal Volume
548
Journal Issue
1-2
Journal Page Range
p. 17-22
ISSN
0168-9002
CODEN
NIMAER

Conference

Title
4. international workshop on medical applications of synchrotron radiation
Acronym
MASR2004
Dates
23-25 Sep 2004
Place
Trieste (Italy)

Optional Information

Copyright
Copyright (c) 2005 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.